[Endorphins--endogenous peptides with morphine-like effects. 2. Biological importance, clinical apsects].
Since 1974 peptides with opiate-like action both in vivo and in vitro have been isolated from the nervous system of various vertebrates and man. The localization of these peptides (endorphins) within the central and peripheral nervous system reflects the possible biological functions in which they may participate: the response of the CNS to painful stimuli (dorsal horn of the spinal cord, central grey matter, thalamus); the control of emotions (limbic system); the regulation of vegetative functions (medulla oblongata); the response of the body to stress the control of endocrine function (hypothalamus, infundibulum, hypophysis); the control of extrapyramidal motor activity (brain stem) or the control of intestinal motility (intramural nervous plexus). Up-to-date knowledge suggests that the endorphins may function as neurotransmitters, neuromodulators or hormones and that such functions vary according to the special sites of synthesis, storage and action of these various peptides within the body.
D001519:Behavior / Q000187:drug effects; D001833:Body Temperature Regulation / Q000187:drug effects; D004361:Drug Tolerance; D004723:Endorphins / Q000502:physiology*; D004745:Enkephalins / Q000627:therapeutic use; D004827:Epilepsy / Q000188:drug therapy; D005260:Female; D005769:Gastrointestinal Motility / Q000187:drug effects; D006801:Humans; D007858:Learning / Q000187:drug effects; D009270:Naloxone / Q000494:pharmacology; D000699:Pain Insensitivity, Congenital / Q000188:drug therapy; D011247:Pregnancy; D013315:Stress, Psychological / Q000187:drug effects
D004723:Endorphins; D004745:Enkephalins; D009270:Naloxone
Endorphine--körpereigene Peptide mit Morphin-ähnlicher Wirkung. Teil 2: Biologische Bedeutung, klinische Gesichtspunkte.